Newsroom

March 2, 2020

Valisure Detects NDMA in Metformin

March 6, 2024

Valisure Detects Benzene in Benzoyl Peroxide

March 7, 2024

What is "Stability Testing" & Why it's Important

January 1, 2023

GOJO & Valisure: Promoting Public Health Through Collaboration

November 4, 2021

Valisure Detects Benzene in Body Spray

June 13, 2019

Valisure Detects DMF in Valsartan

March 24, 2021

Valisure Detects Benzene in Hand Sanitizer

Responsible Disposal of Contaminated Products

November 1, 2022

Valisure Detects Benzene in Dry Shampoo

May 17, 2024

Valisure’s FDA Citizen Petitions

May 17, 2024

FDA Citizen Petition #4: Benzene in Hand Sanitizer Products

May 17, 2024

FDA Citizen Petition #7: Benzene in Dry Shampoo Products

May 17, 2024

FDA Citizen Petition #2: NDMA Carcinogen in Ranitidine (Zantac) & Nizatidine (Axid)

May 17, 2024

FDA Citizen Petition #3: NDMA Carcinogen in Metformin

May 17, 2024

FDA Citizen Petition #6: Benzene in Body Spray Products

May 17, 2024

FDA Citizen Petition #5: Benzene in Sunscreen Products

May 17, 2024

FDA Citizen Petition #1: DMF Carcinogen in Valsartan

March 6, 2024

FDA Citizen Petition #8: Benzene in Benzoyl Peroxide Products

April 18, 2022

JAMA Network: Analysis of Ranitidine-Associated N-Nitrosodimethylamine Production Under Simulated Physiologic Conditions

April 18, 2022

Your Medication May Not Be Dissolving Properly: Valisure’s Testing Of Ibuprofen With Real-World Conditions Reveals Significant Issues

April 18, 2022

medRxiv: Evidence-Based Quality Scores for Rating Drug Products and Their Utility in Health Systems

April 18, 2022

Environmental Health Perspectives: Independent Sun Care Product Screening for Benzene Contamination

March 31, 2022

Scientific Studies Show Ranitidine Associated With Carcinogen Formation And Variations In Cancer Diagnoses

March 2, 2023

JAPhA: A Data-Driven Quality-Score System

May 18, 2022

JDD: Dermatologists’ Responses to Benzene Being Reported as a Contaminant in Sunscreen: A Cross-Sectional Analysis

May 18, 2023

David Light Invited To Present at Stanford Medicine Grand Rounds

April 18, 2022

Valisure Participation in Virtual Summit on Safe, Effective, & Accessible High-Quality Medicines

April 25, 2022

Valisure Participation in CHPA Regulatory, Scientific & Quality Conference

April 18, 2022

The People’s Pharmacy Webinar: Contamination in Consumer Products

October 21, 2022

Valisure Joins End Drug Shortages Alliance

September 12, 2023

Valisure Attends AHRMM Annual Conference

December 27, 2023

Health Affairs | Ensuring Access To Generic Medications In The US

December 27, 2023

Health Affairs | How To Ensure The Quality And Safety Of Our Generic Drugs

March 5, 2024

Bloomberg's The Business of Bad Medicine Column

March 29, 2022

CBS News | Potentially Dangerous Chemical Found in Popular Heartburn Pill Zantac

December 27, 2023

Buzzfeed | A Viral TikTok

February 26, 2024

Bloomberg | US Military Is So Worried About Drug Safety It Wants to Test Widely Used Medicines

April 20, 2022

The New York Times | Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

March 29, 2022

The Washington Post | ‘Rapid release’ Tylenol gelcaps are slower to dissolve than cheaper tablets, study finds

March 31, 2022

Bloomberg | Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug

March 29, 2022

HBW Insight | Valisure’s Benzene Testing Finds Problems With OTC Sunscreens, Cosmetic Sun Care Products

May 4, 2022

The New York Times | Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk

April 20, 2022

U.S. Senator Chris Murphy Honors Valisure With His Office’s Innovator Award

April 20, 2022

Valisure Wins Pre-Revenue Venture Of The Year In 2018 CT Entrepreneur Awards

April 18, 2022

Valisure First Company To Be Named By MedPage As A Healthcare Disruptor

May 2, 2022

Valisure Named Honorable Mention in Category of Fast Company’s 2022 World Changing Ideas Awards

April 20, 2022

David Light Awarded Junior Achievement's Entrepreneur of The Year Award

May 25, 2023

Congresswoman Rosa DeLauro’s Letter to FDA On GSK’s Actions